Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orli Wargon

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
The Journal of Pediatrics|September 5, 2017
Prenatal Risk Factors for PHACE Syndrome: A Study Using the PHACE Syndrome International Clinical Registry and Genetic RepositoryJoy Wan, Jack Steiner, Eulalia Baselga, et al.
The Australasian Journal of Dermatology|March 11, 2015
Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statementEmma Mooney, Marius Rademaker, Rebecca Dailey, et al.
The American Journal of Cardiology|October 2, 2013
Congenital cardiac, aortic arch, and vascular bed anomalies in PHACE syndrome (from the International PHACE Syndrome Registry)Michelle L Bayer, Peter C Frommelt, Francine Blei, et al.
The Australasian Journal of Dermatology|March 3, 2017
Consensus statement for the treatment of infantile haemangiomas with propranololSarah L Smithson, Marius Rademaker, Susan Adams, et al.
Journal of Paediatrics and Child Health|June 1, 2026
Development of Multidisciplinary Consensus-Informed Guidance for the Management of Paediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Clinicians From Australasian Tertiary Referral HospitalsPatrick David Mahar, Thomas Lee, David Orchard, et al.
Circulation|July 9, 2017
Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK SignalingMustapha Amyere, Nicole Revencu, Raphaël Helaers, et al.
The New England Journal of Medicine|February 19, 2015
A randomized, controlled trial of oral propranolol in infantile hemangiomaChristine Léauté-Labrèze, Peter Hoeger, Juliette Mazereeuw-Hautier, et al.
Human Mutation|September 17, 2013
RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformationNicole Revencu, Laurence M Boon, Antonella Mendola, et al.
Science Immunology|June 17, 2018
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activityVivien Béziat, Juan Li, Jian-Xin Lin, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The Journal of Pediatrics|September 5, 2017
Prenatal Risk Factors for PHACE Syndrome: A Study Using the PHACE Syndrome International Clinical Registry and Genetic RepositoryJoy Wan, Jack Steiner, Eulalia Baselga, et al.
The Australasian Journal of Dermatology|March 11, 2015
Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statementEmma Mooney, Marius Rademaker, Rebecca Dailey, et al.
The American Journal of Cardiology|October 2, 2013
Congenital cardiac, aortic arch, and vascular bed anomalies in PHACE syndrome (from the International PHACE Syndrome Registry)Michelle L Bayer, Peter C Frommelt, Francine Blei, et al.
The Australasian Journal of Dermatology|March 3, 2017
Consensus statement for the treatment of infantile haemangiomas with propranololSarah L Smithson, Marius Rademaker, Susan Adams, et al.
Journal of Paediatrics and Child Health|June 1, 2026
Development of Multidisciplinary Consensus-Informed Guidance for the Management of Paediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Clinicians From Australasian Tertiary Referral HospitalsPatrick David Mahar, Thomas Lee, David Orchard, et al.
Circulation|July 9, 2017
Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK SignalingMustapha Amyere, Nicole Revencu, Raphaël Helaers, et al.
The New England Journal of Medicine|February 19, 2015
A randomized, controlled trial of oral propranolol in infantile hemangiomaChristine Léauté-Labrèze, Peter Hoeger, Juliette Mazereeuw-Hautier, et al.
Human Mutation|September 17, 2013
RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformationNicole Revencu, Laurence M Boon, Antonella Mendola, et al.
Science Immunology|June 17, 2018
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activityVivien Béziat, Juan Li, Jian-Xin Lin, et al.
Pageof 5